254 related articles for article (PubMed ID: 9880385)
21. Risk factors of symptomatic intracerebral hemorrhage after tPA therapy for acute stroke.
Lansberg MG; Thijs VN; Bammer R; Kemp S; Wijman CA; Marks MP; Albers GW;
Stroke; 2007 Aug; 38(8):2275-8. PubMed ID: 17569874
[TBL] [Abstract][Full Text] [Related]
22. Severe Hemorrhagic Transformation after Thrombolysis for Acute Ischemic Stroke Prevents Early Neurological Improvement.
Gill D; Baheerathan A; Aravind A; Veltkamp R; Kar A
J Stroke Cerebrovasc Dis; 2016 Sep; 25(9):2232-6. PubMed ID: 27318653
[TBL] [Abstract][Full Text] [Related]
23. Computed Tomography--Verified Leukoaraiosis Is a Risk Factor for Post-thrombolytic Hemorrhage.
Willer L; Havsteen I; Ovesen C; Christensen AF; Christensen H
J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1126-30. PubMed ID: 25920756
[TBL] [Abstract][Full Text] [Related]
24. The NAG scale: Noble Predictive Scale for Hematoma Expansion in Intracerebral Hemorrhage.
Sakuta K; Sato T; Komatsu T; Sakai K; Terasawa Y; Mitsumura H; Iguchi Y
J Stroke Cerebrovasc Dis; 2018 Oct; 27(10):2606-2612. PubMed ID: 29958849
[TBL] [Abstract][Full Text] [Related]
25. Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study.
Albers GW; Bates VE; Clark WM; Bell R; Verro P; Hamilton SA
JAMA; 2000 Mar; 283(9):1145-50. PubMed ID: 10703776
[TBL] [Abstract][Full Text] [Related]
26. Frequency and predictors of symptomatic intracerebral hemorrhage in patients with ischemic stroke treated with recombinant tissue plasminogen activator outside clinical trials.
Martí-Fàbregas J; Bravo Y; Cocho D; Martí-Vilalta JL; Díaz-Manera J; San Román L; Puig M; Blanco M; Castellanos M; Millán M; Roquer J; Obach V; Maestre J
Cerebrovasc Dis; 2007; 23(2-3):85-90. PubMed ID: 17114877
[TBL] [Abstract][Full Text] [Related]
27. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?
Hermann A; Dzialowski I; Koch R; Gahn G
J Neurol Sci; 2009 Sep; 284(1-2):155-7. PubMed ID: 19473668
[TBL] [Abstract][Full Text] [Related]
28. Recanalization between 1 and 24 hours after t-PA therapy is a strong predictor of cerebral hemorrhage in acute ischemic stroke patients.
Kimura K; Iguchi Y; Shibazaki K; Kobayashi K; Uemura J; Aoki J; Yamashita S; Terasawa Y; Matsumoto N
J Neurol Sci; 2008 Jul; 270(1-2):48-52. PubMed ID: 18304581
[TBL] [Abstract][Full Text] [Related]
29. A risk score to predict intracranial hemorrhage after recombinant tissue plasminogen activator for acute ischemic stroke.
Cucchiara B; Tanne D; Levine SR; Demchuk AM; Kasner S
J Stroke Cerebrovasc Dis; 2008; 17(6):331-3. PubMed ID: 18984422
[TBL] [Abstract][Full Text] [Related]
30. Older age does not increase risk of hemorrhagic complications after intravenous and/or intra-arterial thrombolysis for acute stroke.
Pundik S; McWilliams-Dunnigan L; Blackham KL; Kirchner HL; Sundararajan S; Sunshine JL; Tarr RW; Selman WR; Landis DM; Suarez JI
J Stroke Cerebrovasc Dis; 2008 Sep; 17(5):266-72. PubMed ID: 18755405
[TBL] [Abstract][Full Text] [Related]
31. Predictors of Symptomatic Intracranial Hemorrhage after Endovascular Therapy in Acute Ischemic Stroke with Large Vessel Occlusion.
Sugiura Y; Yamagami H; Sakai N; Yoshimura S;
J Stroke Cerebrovasc Dis; 2017 Apr; 26(4):766-771. PubMed ID: 27838178
[TBL] [Abstract][Full Text] [Related]
32. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
33. Carotid duplex ultrasonography can predict outcome of intravenous alteplase therapy for hyperacute stroke.
Koga M; Toyoda K; Nakashima T; Hyun BH; Uehara T; Yokota C; Nagatsuka K; Naritomi H; Minematsu K
J Stroke Cerebrovasc Dis; 2011; 20(1):24-29. PubMed ID: 20538483
[TBL] [Abstract][Full Text] [Related]
34. Local intra-arterial thrombolysis in acute ischemic stroke.
Gönner F; Remonda L; Mattle H; Sturzenegger M; Ozdoba C; Lövblad KO; Baumgartner R; Bassetti C; Schroth G
Stroke; 1998 Sep; 29(9):1894-900. PubMed ID: 9731615
[TBL] [Abstract][Full Text] [Related]
35. The iScore predicts efficacy and risk of bleeding in the National Institute of Neurological disorders and Stroke Tissue Plasminogen Activator Stroke Trial.
Saposnik G; Demchuk A; Tu JV; Johnston SC;
J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):876-82. PubMed ID: 23102741
[TBL] [Abstract][Full Text] [Related]
36. Hyperdense middle cerebral artery sign is associated with increased risk of hemorrhagic transformation after intravenous thrombolysis for patients with acute ischaemic stroke.
Zou M; Churilov L; He A; Campbell B; Davis SM; Yan B
J Clin Neurosci; 2013 Jul; 20(7):984-7. PubMed ID: 23664409
[TBL] [Abstract][Full Text] [Related]
37. Symptomatic intracerebral hemorrhage after intravenous thrombolysis in Chinese patients: comparison of prediction models.
Li M; Wang-Qin RQ; Wang YL; Liu LB; Pan YS; Liao XL; Wang YJ; Xu AD
J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1235-43. PubMed ID: 25891755
[TBL] [Abstract][Full Text] [Related]
38. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
[TBL] [Abstract][Full Text] [Related]
39. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.
Clark WM; Wissman S; Albers GW; Jhamandas JH; Madden KP; Hamilton S
JAMA; 1999 Dec; 282(21):2019-26. PubMed ID: 10591384
[TBL] [Abstract][Full Text] [Related]
40. Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial.
Bruno A; Levine SR; Frankel MR; Brott TG; Lin Y; Tilley BC; Lyden PD; Broderick JP; Kwiatkowski TG; Fineberg SE;
Neurology; 2002 Sep; 59(5):669-74. PubMed ID: 12221155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
